WADA will not appeal UCI verdict on Chris Froome salbutamol case

The World Anti-Doping Agency announced on Monday that it will not appeal the UCI's decision to clear Chris Froome of any anti-doping rule violations from the 2017 Vuelta a Espana. The agency's press release confirmed that Froome did not undergo the controlled pharmacokinetic study (CPKS) allowed under WADA rules to prove that the level of salbutamol in his Vuelta urine sample that exceeded the allowed threshold was a normal consequence of his physiology.

Thank you for reading 5 articles in the past 30 days*

Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read any 5 articles for free in each 30-day period, this automatically resets

After your trial you will be billed £4.99 $7.99 €5.99 per month, cancel anytime. Or sign up for one year for just £49 $79 €59

Join now for unlimited access

Try your first month for just £1 / $1 / €1